X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3438) 3438
Publication (471) 471
Newsletter (301) 301
Book Review (26) 26
Dissertation (10) 10
Book Chapter (7) 7
Conference Proceeding (2) 2
Book / eBook (1) 1
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1909) 1909
animals (1682) 1682
glycogen-synthase kinase-3 (1368) 1368
humans (1323) 1323
glycogen (1302) 1302
phosphorylation (1267) 1267
glycogen synthase kinase 3 - metabolism (1118) 1118
synthesis (898) 898
mice (895) 895
glycogen synthase kinase 3 beta (817) 817
kinases (777) 777
signal transduction (734) 734
neurosciences (645) 645
cell biology (637) 637
apoptosis (629) 629
proteins (620) 620
male (615) 615
research (612) 612
biochemistry & molecular biology (597) 597
glycogen synthase kinase 3 (592) 592
activation (501) 501
rats (449) 449
research article (440) 440
beta-catenin (432) 432
glycogen synthase kinase 3 - antagonists & inhibitors (430) 430
proto-oncogene proteins c-akt - metabolism (391) 391
female (384) 384
article (379) 379
expression (376) 376
inhibition (374) 374
multidisciplinary sciences (367) 367
glycogen synthase kinase 3 - genetics (362) 362
cell line, tumor (356) 356
medicine (348) 348
signal transduction - drug effects (342) 342
gene expression (335) 335
physiological aspects (319) 319
alzheimer's disease (318) 318
gsk3 (311) 311
alzheimers-disease (303) 303
lithium (302) 302
science (302) 302
cancer (300) 300
oncology (298) 298
glycogen-synthase kinase-3-beta (297) 297
rodents (286) 286
insulin (283) 283
cells, cultured (274) 274
biology (265) 265
analysis (260) 260
brain (257) 257
cell line (248) 248
mice, inbred c57bl (242) 242
beta catenin - metabolism (236) 236
pharmacology & pharmacy (232) 232
akt (231) 231
macromolecular substances (227) 227
glycogen synthase kinase 3 beta - metabolism (218) 218
akt protein (217) 217
neurons (216) 216
β-catenin (215) 215
protein-kinase (212) 212
phosphorylation - drug effects (211) 211
gsk3β (210) 210
disease models, animal (209) 209
signaling (208) 208
cell proliferation (206) 206
pathway (205) 205
glucose metabolism (202) 202
metabolism (200) 200
biochemistry (199) 199
oxidative stress (198) 198
gene-expression (197) 197
signal transduction - physiology (194) 194
apoptosis - drug effects (192) 192
in-vivo (191) 191
cells (190) 190
phosphatidylinositol 3-kinases - metabolism (189) 189
genetic aspects (186) 186
health aspects (186) 186
inflammation (186) 186
gsk3 beta (185) 185
physiology (183) 183
enzyme inhibitors - pharmacology (179) 179
cell cycle (174) 174
glucose (170) 170
bipolar disorder (169) 169
rats, sprague-dawley (167) 167
stem cells (167) 167
blotting, western (164) 164
signaling pathway (164) 164
protein (163) 163
enzymes (158) 158
protein kinases (156) 156
endocrinology & metabolism (154) 154
tau proteins - metabolism (154) 154
diabetes (152) 152
glycogen synthase kinase-3β (151) 151
neurology (151) 151
insulin resistance (150) 150
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3743) 3743
French (2) 2
Chinese (1) 1
Japanese (1) 1
Portuguese (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 02/2015, Volume 290, Issue 9, pp. 5592 - 5605
Glycogen synthase kinase-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ranging from the control of glycogen... 
SURVIVAL | MTORC1 | RAG GTPASES | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | BIOLOGY | TFEB | NF-KAPPA-B | GEMCITABINE | LYSOSOMAL BIOGENESIS | Pancreatic Neoplasms - metabolism | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Humans | Cell Survival - genetics | Apoptosis - genetics | Immunoblotting | Green Fluorescent Proteins - genetics | Autophagy - drug effects | TOR Serine-Threonine Kinases - antagonists & inhibitors | Cell Nucleus - metabolism | RNA Interference | Mass Spectrometry | HEK293 Cells | Autophagy - genetics | Cell Line | Cell Survival - drug effects | Green Fluorescent Proteins - metabolism | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Pancreatic Neoplasms - pathology | Cells, Cultured | Pancreatic Neoplasms - genetics | Pyrimidines - pharmacology | Glycogen Synthase Kinase 3 - metabolism | Mice, Knockout | Microscopy, Confocal | Animals | Glycogen Synthase Kinase 3 - genetics | Active Transport, Cell Nucleus - drug effects | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Cell Line, Tumor | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Pyridines - pharmacology | Naphthyridines - pharmacology | Glycogen Synthase Kinase 3 (GSK-3) | 14-3-3 Protein | Pancreatic Cancer | Transcription Factor | Autophagy | Cell Biology | Apoptosis
Journal Article
The International Journal of Neuropsychopharmacology, ISSN 1461-1457, 9/2011, Volume 14, Issue 8, pp. 1051 - 1067
There is a growing body of evidence suggesting that animal models can be developed to probe the specific domains of bipolar disorder (BD) using the... 
bipolar disorder | hyperactivity | mood stabilizers | Antimanic drugs | antipsychotic drugs | PREPULSE INHIBITION | PSYCHIATRY | INDUCED LOCOMOTOR STIMULATION | DOPAMINE TRANSPORTER | NEUROSCIENCES | CLINICAL NEUROLOGY | MOUSE MODEL | DOUBLE-BLIND | STAIRCASE TEST | ANIMAL-MODELS | PHARMACOLOGY & PHARMACY | ACUTE BIPOLAR MANIA | D-AMPHETAMINE | Central Nervous System Stimulants - pharmacology | Antipsychotic Agents - adverse effects | Humans | Maleimides - pharmacology | Motor Activity - drug effects | Male | Thiazoles - therapeutic use | Molecular Targeted Therapy | Dose-Response Relationship, Drug | Thiadiazoles - adverse effects | Maleimides - therapeutic use | Central Nervous System Stimulants - adverse effects | Antipsychotic Agents - therapeutic use | Mice, Mutant Strains | Thiadiazoles - therapeutic use | Urea - analogs & derivatives | Indoles - pharmacology | Drug Therapy, Combination | Antimanic Agents - adverse effects | Disease Models, Animal | Thiadiazoles - pharmacology | Reproducibility of Results | Antimanic Agents - therapeutic use | Antimanic Agents - pharmacology | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Amphetamine - pharmacology | Amphetamine - adverse effects | Glycogen Synthase Kinase 3 - metabolism | Bipolar Disorder - drug therapy | Blood-Brain Barrier - drug effects | Urea - therapeutic use | Animals | Indoles - therapeutic use | Mice | Thiazoles - pharmacology | Antipsychotic Agents - pharmacology | Urea - pharmacology | Psychotropic drugs | Drug therapy | Antidepressants | Rodents
Journal Article
Developmental and Comparative Immunology, ISSN 0145-305X, 08/2017, Volume 73, p. 144
Glycogen synthase kinase-3 (GSK3) is a serine/threonine protein kinase firstly identified as a regulator of glycogen synthesis. Recently, it has been proved to... 
Immune response | Threonine | Crabs | Medical immunity | Muscles | Glycogen synthase kinase 3 | Amino acids | Lithium | Homology | Rivers | Phylogeny | Tumor necrosis factor-α | Kinases | Gene expression | Vertebrates | Crustaceans | Phylogenetics | Protein-serine/threonine kinase | Immunofluorescence | Phagocytosis | Cytoplasm | Deoxyribonucleic acid--DNA | Hemocytes | Immune system
Journal Article